Patients (n = 22 patients/25 eyes) | Control (n = 10) | p-valuea | |
---|---|---|---|
Eotaxin | |||
Range | 2.59–16.22 | 2.02–5.78 | 0.043* |
Median (IQR) | 5.27 (4.11–7.50) | 4.32 (2.02–5.16) | |
IP-10 | |||
Range | 0.0–3530.16 | 52.02–509.38 | 0.037* |
Median (IQR) | 213.02 (151.75–335.65) | 136.35 (94.31–169.1) | |
MCP-1 | |||
Range | 121.89–1205.45 | 89.81–446.45 | 0.001* |
Median (IQR) | 213.63 (162.54–292.0) | 130.46 (96.38 - 138.97) | |
IFN-gamma | |||
Range | 0.0–6.21 | 0.78–3.22 | 0.003* |
Median (IQR) | 0.52 (0.0–1.13) | 1.51 (1.32–2.80) | |
Basic-FGF | |||
Range | 0.0–56.65 | 0.0–40.08 | 0.100 |
Median (IQR) | 18.24 (0.0–30.26) | 30.26 (30.26–40.08) | |
IL-8 | |||
Range | 0.0–47.86 | 0.0–35.52 | 0.015* |
Median (IQR) | 16.96 (6.94–31.27) | 3.45 (0.0–6.94) | |
G-CSF | |||
Range | 0.0–46.03 | 9.04–65.37 | 0.019* |
Median (IQR) | 4.23 (0.0–14.68) | 13.57 (11.33–22.21) | |
IL-1ra | |||
Range | 0.0–1351.34 | 93.27–382.12 | 0.070 |
Median (IQR) | 149.65 (0.0–298.27) | 266.64 (193.9–327.79) |